RETRACTION: The Noncytotoxic Dose of Sorafenib Sensitizes Bel-7402/5-FU Cells to 5-FU by Down-Regulating 5-FU-Induced Nrf2 Expression (Retraction of Vol 58, Pg 1615, 2013)

被引:0
|
作者
Zhou, Suna [1 ,2 ]
Ye, Wenguang [3 ]
Duan, Xiaoyi [4 ]
Zhang, Mingxin [3 ]
Wang, Jiansheng [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Med Sch, Dept Thorac Oncol, Yanta West Rd 277, Xian 710061, Shaanxi, Peoples R China
[2] Fourth Mil Med Univ, Tangdu Hosp, Dept Radiotherapy, Xian, Shaanxi, Peoples R China
[3] Fourth Mil Med Univ, Tangdu Hosp, Dept Gastroenterol, Xian, Shaanxi, Peoples R China
[4] Xi An Jiao Tong Univ, Affiliated Hosp 1, Med Sch, Dept Nucl Med, Xian, Shaanxi, Peoples R China
关键词
PROLIFERATION; INVASION;
D O I
10.1007/s10620-023-08047-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:3826 / 3826
页数:1
相关论文
共 44 条
  • [31] rpL3 promotes the apoptosis of p53 mutated lung cancer cells by down-regulating CBS and NFκB upon 5-FU treatment
    Russo, Annapina
    Saide, Assunta
    Cagliani, Roberta
    Cantile, Monica
    Botti, Gerardo
    Russo, Giulia
    SCIENTIFIC REPORTS, 2016, 6
  • [32] RETRACTION: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance (Retraction of Vol 9, Pg 1185, 2018)
    Intuyod, Kitti
    Saavedra-Garcia, Paula
    Zona, Stefania
    Lai, Chun-Fui
    Jiramongkol, Yannasittha
    Vaeteewoottacharn, Kulthida
    Pairojkul, Chawalit
    Yao, Shang
    Yong, Jay-Sze
    Trakansuebkul, Sasanan
    Waraasawapati, Sakda
    Luvira, Vor
    Wongkham, Sopit
    Pinlaor, Somchai
    Lam, Eric W. -F.
    CELL DEATH & DISEASE, 2021, 12 (06)
  • [33] Oroxylin a reverses multi-drug resistance of human hepatoma BEL7402/5-FU cells via downregulation of P-glycoprotein expression by inhibiting NF-?B signaling pathway
    Yang, Hui-Ying
    Zhao, Li
    Yang, Zhen
    Zhao, Qing
    Qiang, Lei
    Ha, Jun
    Li, Zhi-Yu
    You, Qi-Dong
    Guo, Qing-Long
    MOLECULAR CARCINOGENESIS, 2012, 51 (02) : 185 - 195
  • [34] RETRACTION: A water-stable and biofriendly Zn-MOF with pyrazine decorated pores as 5-Fu delivery system to induce human ovarian cancer cells apoptosis and abrogate their growth (Retraction of Vol 1204, art no 127477, 2020)
    Yan, Zhonghua
    Li, Xiaohui
    Fan, Qianqian
    Bai, Hua
    Wu, Suhui
    Zhang, Zhi-Fang
    Pan, Lei
    JOURNAL OF MOLECULAR STRUCTURE, 2023, 1275
  • [35] RETRACTION: Piperine alleviates lipopolysaccharide-induced inflammatory injury by down-regulating microRNA-127 in murine chondrogenic ATDC5 cells (Retraction of Vol 103, Pg 947, 2018)
    Ren, Chunfeng
    Liang, Zhiyuan
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 149
  • [36] IGF-1 upregulates Survivin expression through PI-3K and CK2 pathways to inhibit 5-Fu induced apoptosis in esophageal carcinoma cells
    Wong, Fen-Hwa
    Juan, Hsien-Chia
    Tsai, Hsin-Ting
    Huang, Chi-Ying F.
    CANCER RESEARCH, 2006, 66 (08)
  • [37] RETRACTION: Tanshinone IIA protects murine chondrogenic ATDC5 cells from lipopolysaccharide-induced inflammatory injury by down-regulating microRNA-203a (Vol 103, pg 28, 2018) (Retraction of Vol 103, Pg 628, 2018)
    Luan, Luan
    Liang, Zhiyuan
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 153
  • [38] RETRACTED: EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression (Retracted article. See vol. 16, pg. 673, 2023)
    Wang, Chenyu
    Li, Xingwang
    Zhang, Junjie
    Ge, Zheng
    Chen, Hejin
    Hu, Junhong
    ONCOTARGETS AND THERAPY, 2018, 11 : 7853 - 7864
  • [39] MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer (vol 6, e1845, 2015)
    Zhang, Yang
    Talmon, G.
    Wang, J.
    CELL DEATH & DISEASE, 2016, 7 : e2525 - e2525
  • [40] RETRACTION: Long Non-Coding RNA EGOT Promotes the Malignant Phenotypes of Hepatocellular Carcinoma Cells and Increases the Expression of HMGA2 via Down-Regulating miR-33a-5p (Retraction of Vol 12, Pg 11623, 2019)
    Wu, S.
    Ai, H.
    Zhang, K.
    Yun, H.
    Xie, F.
    ONCOTARGETS AND THERAPY, 2022, 15 : 1121 - 1121